BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10950061)

  • 1. Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma.
    Yatsuoka T; Sunamura M; Furukawa T; Fukushige S; Yokoyama T; Inoue H; Shibuya K; Takeda K; Matsuno S; Horii A
    Am J Gastroenterol; 2000 Aug; 95(8):2080-5. PubMed ID: 10950061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for pancreatic cancer based on genetic characterization of the disease.
    Sunamura M; Yatsuoka T; Motoi F; Duda DG; Kimura M; Abe T; Yokoyama T; Inoue H; Oonuma M; Takeda K; Matsuno S
    J Hepatobiliary Pancreat Surg; 2002; 9(1):32-8. PubMed ID: 12021895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of pancreatic carcinogenesis.
    Furukawa T; Sunamura M; Horii A
    Cancer Sci; 2006 Jan; 97(1):1-7. PubMed ID: 16367914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelotype of papillary serous peritoneal carcinomas.
    Cass I; Baldwin RL; Fasylova E; Fields AL; Klinger HP; Runowicz CD; Karlan BY
    Gynecol Oncol; 2001 Jul; 82(1):69-76. PubMed ID: 11426964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelotype analysis of esophageal squamous cell carcinoma.
    Shibagaki I; Shimada Y; Wagata T; Ikenaga M; Imamura M; Ishizaki K
    Cancer Res; 1994 Jun; 54(11):2996-3000. PubMed ID: 8187088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetic alterations in carcinoma ex-pleomorphic adenoma: a putative progression model?
    El-Naggar AK; Callender D; Coombes MM; Hurr K; Luna MA; Batsakis JG
    Genes Chromosomes Cancer; 2000 Feb; 27(2):162-8. PubMed ID: 10612804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed deletion mapping on chromosome arm 12q in human pancreatic adenocarcinoma: identification of a I-cM region of common allelic loss.
    Kimura M; Abe T; Sunamura M; Matsuno S; Horii A
    Genes Chromosomes Cancer; 1996 Oct; 17(2):88-93. PubMed ID: 8913725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation status of K-ras, p53 and allelic losses at 9p and 18q are not prognostic markers in patients with pancreatic cancer.
    Salek C; Minarikova P; Benesova L; Nosek V; Strnad R; Zavoral M; Minarik M
    Anticancer Res; 2009 May; 29(5):1803-10. PubMed ID: 19443408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exclusion of SMAD4 mutation as an early genetic change in human pancreatic ductal tumorigenesis.
    Inoue H; Furukawa T; Sunamura M; Takeda K; Matsuno S; Horii A
    Genes Chromosomes Cancer; 2001 Jul; 31(3):295-9. PubMed ID: 11391801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelotype of pancreatic adenocarcinoma using xenograft enrichment.
    Hahn SA; Seymour AB; Hoque AT; Schutte M; da Costa LT; Redston MS; Caldas C; Weinstein CL; Fischer A; Yeo CJ
    Cancer Res; 1995 Oct; 55(20):4670-5. PubMed ID: 7553647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent loss of heterozygosity at the DCC locus in gastric cancer.
    Uchino S; Tsuda H; Noguchi M; Yokota J; Terada M; Saito T; Kobayashi M; Sugimura T; Hirohashi S
    Cancer Res; 1992 Jun; 52(11):3099-102. PubMed ID: 1591722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity analysis in uterine cervical adenocarcinoma.
    Miyai K; Furugen Y; Matsumoto T; Iwabuchi K; Hirose S; Kinoshita K; Fujii H
    Gynecol Oncol; 2004 Jul; 94(1):115-20. PubMed ID: 15262128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
    Phelan CM; Borg A; Cuny M; Crichton DN; Baldersson T; Andersen TI; Caligo MA; Lidereau R; Lindblom A; Seitz S; Kelsell D; Hamann U; Rio P; Thorlacius S; Papp J; Olah E; Ponder B; Bignon YJ; Scherneck S; Barkardottir R; Borresen-Dale AL; Eyfjörd J; Theillet C; Thompson AM; Larsson C
    Cancer Res; 1998 Mar; 58(5):1004-12. PubMed ID: 9500463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q.
    Yamaguchi T; Toguchida J; Yamamuro T; Kotoura Y; Takada N; Kawaguchi N; Kaneko Y; Nakamura Y; Sasaki MS; Ishizaki K
    Cancer Res; 1992 May; 52(9):2419-23. PubMed ID: 1568211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity predicts poor survival after resection of pancreatic adenocarcinoma.
    Franko J; Krasinskas AM; Nikiforova MN; Zarnescu NO; Lee KK; Hughes SJ; Bartlett DL; Zeh HJ; Moser AJ
    J Gastrointest Surg; 2008 Oct; 12(10):1664-72; discussion 1672-3. PubMed ID: 18677542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide allelotyping analysis reveals multiple sites of allelic loss in gallbladder carcinoma.
    Wistuba II; Tang M; Maitra A; Alvarez H; Troncoso P; Pimentel F; Gazdar AF
    Cancer Res; 2001 May; 61(9):3795-800. PubMed ID: 11325854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors.
    Hessman O; Lindberg D; Einarsson A; Lillhager P; Carling T; Grimelius L; Eriksson B; Akerström G; Westin G; Skogseid B
    Genes Chromosomes Cancer; 1999 Nov; 26(3):258-64. PubMed ID: 10502325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of K-ras, BRCA1/2, CHEK2 mutations and microsatellite markers (loss of heterozygosity at 9p, 17p and 18q) in sporadic pancreas adenocarcinomas].
    Amosenko FA; Kazubskaia TP; Gromyko OE; Matveeva TI; Korchagina EL; Nasedkina TV; Gar'kavtseva RF; Kalinin VN
    Mol Biol (Mosk); 2009; 43(3):414-21. PubMed ID: 19548527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
    Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
    Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated analysis of copy number alterations and loss of heterozygosity in human pancreatic cancer using a high-resolution, single nucleotide polymorphism array.
    Lin LJ; Asaoka Y; Tada M; Sanada M; Nannya Y; Tanaka Y; Tateishi K; Ohta M; Seto M; Sasahira N; Tada M; Kawabe T; Zheng CQ; Kanai F; Ogawa S; Omata M
    Oncology; 2008; 75(1-2):102-12. PubMed ID: 18787345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.